Français
ItalianoBond GlaxoSmithKline Capital PLC 1.375% ( XS1681520356 ) in EUR
| Issuer | GlaxoSmithKline Capital PLC | ||||||||||||||||||||
| Market price | 87.54 % ▼ | ||||||||||||||||||||
| Country |  United Kingdom
|
||||||||||||||||||||
| ISIN code |
 XS1681520356 ( in EUR )
|
||||||||||||||||||||
| Interest rate | 1.375% per year ( payment 1 time a year) | ||||||||||||||||||||
| Maturity | 12/09/2029 - Bond has expired | ||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||
| Minimal amount | 100 000 EUR | ||||||||||||||||||||
| Total amount | 500 000 000 EUR | ||||||||||||||||||||
| Detailed description |
GlaxoSmithKline Capital PLC is a UK-based venture capital firm focused on life sciences investments, primarily supporting early-stage and growth-stage companies developing innovative therapies and technologies within GlaxoSmithKline's strategic areas of interest. The Bond issued by GlaxoSmithKline Capital PLC ( United Kingdom ) , in EUR, with the ISIN code XS1681520356, pays a coupon of 1.375% per year. The coupons are paid 1 time per year and the Bond maturity is 12/09/2029 |
||||||||||||||||||||
| |||||||||||||||||||||